{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:03:37Z","timestamp":1789718617560,"version":"4.0.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"DOI":"10.1007\/s11886-026-02416-x","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:30:49Z","timestamp":1789716649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Female Cardiovascular Health After Childhood Cancer"],"prefix":"10.1007","volume":"28","author":[{"given":"Sunnia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L","family":"Repp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Teran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3507-2296","authenticated-orcid":false,"given":"Lavanya","family":"Kondapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2416_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1158\/1055-9965.EPI-14-1418","volume":"24","author":"SM Phillips","year":"2015","unstructured":"Phillips SM, Padgett LS, Leisenring WM, Stratton KK, Bishop K, Krull KR, et al. Survivors of Childhood Cancer in the United States: Prevalence and Burden of Morbidity. Cancer Epidemiol Biomarkers Prev. 2015;24:653\u201363. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-1418.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2416_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc3634","volume":"14","author":"LL Robison","year":"2014","unstructured":"Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014;14:61\u201370. https:\/\/doi.org\/10.1038\/nrc3634.","journal-title":"Nat Rev Cancer"},{"key":"2416_CR3","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.1200\/jco.2008.26.15_suppl.9509","volume":"26","author":"DA Mulrooney","year":"2008","unstructured":"Mulrooney DA, Yeazel M, Mitby P, Kawashima T, Leisenring WM, Stovall M, et al. Cardiovascular disease in adult survivors of childhood and adolescent cancer: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol Wolters Kluwer. 2008;26:9509\u20139509. https:\/\/doi.org\/10.1200\/jco.2008.26.15_suppl.9509.","journal-title":"J Clin Oncol Wolters Kluwer"},{"key":"2416_CR4","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","volume":"31","author":"GT Armstrong","year":"2013","unstructured":"Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W, et al. Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer. J Clin Oncol. 2013;31:3673\u201380. https:\/\/doi.org\/10.1200\/JCO.2013.49.3205.","journal-title":"J Clin Oncol"},{"key":"2416_CR5","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1001\/jama.2013.6296","volume":"309","author":"MM Hudson","year":"2013","unstructured":"Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, et al. Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer. JAMA. 2013;309:2371. https:\/\/doi.org\/10.1001\/jama.2013.6296.","journal-title":"JAMA"},{"key":"2416_CR6","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic Health Conditions in Adult Survivors of Childhood Cancer. N Engl J Med. 2006;355:1572\u201382. https:\/\/doi.org\/10.1056\/NEJMsa060185.","journal-title":"N Engl J Med"},{"key":"2416_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","volume":"43","author":"J Herrmann","year":"2022","unstructured":"Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, et al. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J. 2022;43:280\u201399. https:\/\/doi.org\/10.1093\/eurheartj\/ehab674.","journal-title":"Eur Heart J"},{"key":"2416_CR8","doi-asserted-by":"publisher","first-page":"134679","DOI":"10.4061\/2011\/134679","volume":"2011","author":"VI Franco","year":"2011","unstructured":"Franco VI, Henkel JM, Miller TL, Lipshultz SE. Cardiovascular effects in childhood cancer survivors treated with anthracyclines. Cardiol Res Pract. 2011;2011:134679. https:\/\/doi.org\/10.4061\/2011\/134679.","journal-title":"Cardiol Res Pract"},{"key":"2416_CR9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJM199103213241205","volume":"324","author":"SE Lipshultz","year":"1991","unstructured":"Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood. N Engl J Med. 1991;324:808\u201315. https:\/\/doi.org\/10.1056\/NEJM199103213241205.","journal-title":"N Engl J Med"},{"key":"2416_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40959-025-00399-2","volume":"11","author":"E Grunblatt","year":"2025","unstructured":"Grunblatt E, Everitt IK, Kinahan K, Didwania A, Winter JN, Meng Z, et al. Longitudinal echocardiographic monitoring and cardiovascular outcomes in adult survivors of childhood cancer. Cardio-Oncol. 2025;11:103. https:\/\/doi.org\/10.1186\/s40959-025-00399-2.","journal-title":"Cardio-Oncol"},{"key":"2416_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/hearts5030027","volume":"5","author":"ML Repp","year":"2024","unstructured":"Repp ML, Edwards MD, Burch CS, Rao A, Chinyere IR. PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology. Hearts. 2024;5:375\u201388. https:\/\/doi.org\/10.3390\/hearts5030027.","journal-title":"Hearts"},{"key":"2416_CR12","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJM199506293322602","volume":"332","author":"SE Lipshultz","year":"1995","unstructured":"Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, et al. Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer. N Engl J Med. 1995;332:1738\u201344. https:\/\/doi.org\/10.1056\/NEJM199506293322602.","journal-title":"N Engl J Med"},{"key":"2416_CR13","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.1997.15.4.1544","volume":"15","author":"JP Krischer","year":"1997","unstructured":"Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol. 1997;15:1544\u201352. https:\/\/doi.org\/10.1200\/JCO.1997.15.4.1544.","journal-title":"J Clin Oncol"},{"key":"2416_CR14","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/S1470-2045(23)00012-8","volume":"24","author":"MJ Ehrhardt","year":"2023","unstructured":"Ehrhardt MJ, Leerink JM, Mulder RL, Mavinkurve-Groothuis A, Kok W, Nohria A, et al. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2023;24:e108\u201320. https:\/\/doi.org\/10.1016\/S1470-2045(23)00012-8.","journal-title":"Lancet Oncol"},{"key":"2416_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13293-018-0198-2","volume":"9","author":"B Meiners","year":"2018","unstructured":"Meiners B, Shenoy C, Zordoky BN. Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity. Biol Sex Differ. 2018;9:38. https:\/\/doi.org\/10.1186\/s13293-018-0198-2.","journal-title":"Biol Sex Differ"},{"key":"2416_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10741-019-09820-2","volume":"24","author":"C Cadeddu Dessalvi","year":"2019","unstructured":"Cadeddu Dessalvi C, Pepe A, Penna C, Gimelli A, Madonna R, Mele D, et al. Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens. Heart Fail Rev. 2019;24:915\u201325. https:\/\/doi.org\/10.1007\/s10741-019-09820-2.","journal-title":"Heart Fail Rev"},{"key":"2416_CR17","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1001\/jama.1990.03450140030022","volume":"264","author":"J Byrne","year":"1990","unstructured":"Byrne J. Sexual Differences in Cancer Survival: Hormones or Stage at Diagnosis? JAMA J Am Med Assoc. 1990;264:1810. https:\/\/doi.org\/10.1001\/jama.1990.03450140030022.","journal-title":"JAMA J Am Med Assoc"},{"key":"2416_CR18","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1001\/jama.1990.03440160051036","volume":"263","author":"HO Adami","year":"1990","unstructured":"Adami HO, Bergstr\u00f6m R, Holmberg L, Klareskog L, Persson I, Pont\u00e9n J. The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA. 1990;263:2189\u201393.","journal-title":"JAMA"},{"key":"2416_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.radonc.2020.09.058","volume":"154","author":"MK Bishr","year":"2021","unstructured":"Bishr MK, Zaghloul MS, Elmaraghi C, Galal A, Abdelaziz MS, Elghazawy HI, et al. The radiotherapy utilization rate in pediatric tumors: An analysis of 13,305 patients. Radiother Oncol. 2021;154:220\u20136. https:\/\/doi.org\/10.1016\/j.radonc.2020.09.058.","journal-title":"Radiother Oncol"},{"key":"2416_CR20","doi-asserted-by":"publisher","unstructured":"Taunk NK, Haffty BG, Kostis JB, Goyal S. Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms. Front Oncol [Internet]. 2015 [cited 2026 May 12];5. https:\/\/doi.org\/10.3389\/fonc.2015.00039","DOI":"10.3389\/fonc.2015.00039"},{"key":"2416_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00018-018-2956-z","volume":"76","author":"B Baselet","year":"2019","unstructured":"Baselet B, Sonveaux P, Baatout S, Aerts A. Pathological effects of ionizing radiation: endothelial activation and dysfunction. Cell Mol Life Sci. 2019;76:699\u2013728. https:\/\/doi.org\/10.1007\/s00018-018-2956-z.","journal-title":"Cell Mol Life Sci"},{"key":"2416_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00392-021-01809-y","volume":"110","author":"M S\u00e1rk\u00f6zy","year":"2021","unstructured":"S\u00e1rk\u00f6zy M, Varga Z, G\u00e1sp\u00e1r R, Sz\u0171cs G, Kov\u00e1cs MG, Kov\u00e1cs ZZA, et al. Pathomechanisms and therapeutic opportunities in radiation-induced heart disease: from bench to bedside. Clin Res Cardiol. 2021;110:507\u201331. https:\/\/doi.org\/10.1007\/s00392-021-01809-y.","journal-title":"Clin Res Cardiol"},{"key":"2416_CR23","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.3390\/ijms24076272","volume":"24","author":"KC Siaravas","year":"2023","unstructured":"Siaravas KC, Katsouras CS, Sioka C. Radiation Treatment Mechanisms of Cardiotoxicity: A Systematic Review. Int J Mol Sci. 2023;24:6272. https:\/\/doi.org\/10.3390\/ijms24076272.","journal-title":"Int J Mol Sci"},{"key":"2416_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cardfail.2024.08.045","volume":"31","author":"MW BLOOM","year":"2025","unstructured":"BLOOM MW, VO JB, RODGERS JE, FERRARI AM, NOHRIA A, DESWAL A, et al. Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America. J Card Fail. 2025;31:415\u201355. https:\/\/doi.org\/10.1016\/j.cardfail.2024.08.045.","journal-title":"J Card Fail"},{"key":"2416_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","volume":"175","author":"FA Van Nimwegen","year":"2015","unstructured":"Van Nimwegen FA, Schaapveld M, Janus CPM, Krol ADG, Petersen EJ, Raemaekers JMM, et al. Cardiovascular Disease After Hodgkin Lymphoma Treatment: 40-Year Disease Risk. JAMA Intern Med. 2015;175:1007. https:\/\/doi.org\/10.1001\/jamainternmed.2015.1180.","journal-title":"JAMA Intern Med"},{"key":"2416_CR26","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","volume":"21","author":"BMP Aleman","year":"2003","unstructured":"Aleman BMP, Van Den Belt-Dusebout AW, Klokman WJ, Van \u2019T, Veer MB, Bartelink H, Van Leeuwen FE. Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin\u2019s Disease. J Clin Oncol. 2003;21:3431\u20139. https:\/\/doi.org\/10.1200\/JCO.2003.07.131.","journal-title":"J Clin Oncol"},{"key":"2416_CR27","doi-asserted-by":"publisher","first-page":"e072924","DOI":"10.1136\/bmj-2022-072924","volume":"380","author":"MP Little","year":"2023","unstructured":"Little MP, Azizova TV, Richardson DB, Tapio S, Bernier M-O, Kreuzer M, et al. Ionising radiation and cardiovascular disease: systematic review and meta-analysis. BMJ. 2023;380:e072924. https:\/\/doi.org\/10.1136\/bmj-2022-072924.","journal-title":"BMJ"},{"key":"2416_CR28","doi-asserted-by":"publisher","first-page":"e012406","DOI":"10.1161\/JAHA.119.012406","volume":"8","author":"JJ Lee","year":"2019","unstructured":"Lee JJ, Cook-Wiens G, Johnson BD, Braunstein GD, Berga SL, Stanczyk FZ, et al. Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute\u2010Sponsored Women\u2019s Ischemia Syndrome Evaluation. J Am Heart Assoc. 2019;8:e012406. https:\/\/doi.org\/10.1161\/JAHA.119.012406.","journal-title":"J Am Heart Assoc"},{"key":"2416_CR29","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1200\/JCO.2011.38.8835","volume":"30","author":"AJ Swerdlow","year":"2012","unstructured":"Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, et al. Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin\u2019s Lymphoma in England and Wales: A National Cohort Study. J Clin Oncol. 2012;30:2745\u201352. https:\/\/doi.org\/10.1200\/JCO.2011.38.8835.","journal-title":"J Clin Oncol"},{"key":"2416_CR30","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1200\/JCO.2003.11.059","volume":"21","author":"S Bhatia","year":"2003","unstructured":"Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, et al. High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin\u2019s Disease: Report From the Late Effects Study Group. J Clin Oncol. 2003;21:4386\u201394. https:\/\/doi.org\/10.1200\/JCO.2003.11.059.","journal-title":"J Clin Oncol"},{"key":"2416_CR31","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1038\/bjc.2013.219","volume":"108","author":"R Cooke","year":"2013","unstructured":"the England and Wales Hodgkin Lymphoma Follow-up Group, Cooke R, Jones ME, Cunningham D, Falk SJ, Gilson D, et al. Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors. Br J Cancer. 2013;108:2399\u2013406. https:\/\/doi.org\/10.1038\/bjc.2013.219.","journal-title":"Br J Cancer"},{"key":"2416_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ijc.34541","volume":"153","author":"A Haavisto","year":"2023","unstructured":"Haavisto A, Wettergren L, Lampic C, L\u00e4hteenm\u00e4ki PM, Jahnukainen K. Premature ovarian insufficiency and chance of pregnancy after childhood cancer: A population-based study (the Fex\u2010Can study). Int J Cancer. 2023;153:644\u201353. https:\/\/doi.org\/10.1002\/ijc.34541.","journal-title":"Int J Cancer"},{"key":"2416_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/EJE-20-1275","volume":"185","author":"A Netterlid","year":"2021","unstructured":"Netterlid A, M\u00f6rse H, Giwercman A, Henic E, \u00c5kesson KE, Erfurth E-M, et al. Premature ovarian failure after childhood cancer and risk of metabolic syndrome: a cross-sectional analysis. Eur J Endocrinol. 2021;185:67\u201375. https:\/\/doi.org\/10.1530\/EJE-20-1275.","journal-title":"Eur J Endocrinol"},{"key":"2416_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","volume":"1","author":"T Muka","year":"2016","unstructured":"Muka T, Oliver-Williams C, Kunutsor S, Laven JSE, Fauser BCJM, Chowdhury R, et al. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiol. 2016;1:767. https:\/\/doi.org\/10.1001\/jamacardio.2016.2415.","journal-title":"JAMA Cardiol"},{"key":"2416_CR35","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.6004\/jnccn.2018.7023","volume":"16","author":"E Gargus","year":"2018","unstructured":"Gargus E, Deans R, Anazodo A, Woodruff TK. Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer. J Natl Compr Canc Netw. 2018;16:1137\u201349. https:\/\/doi.org\/10.6004\/jnccn.2018.7023.","journal-title":"J Natl Compr Canc Netw"},{"key":"2416_CR36","doi-asserted-by":"publisher","first-page":"b4606","DOI":"10.1136\/bmj.b4606","volume":"339","author":"DA Mulrooney","year":"2009","unstructured":"Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606\u20134606. https:\/\/doi.org\/10.1136\/bmj.b4606.","journal-title":"BMJ"},{"key":"2416_CR37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/pbc.22664","volume":"55","author":"G Schellong","year":"2010","unstructured":"Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, B\u00f6lling T, et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German\u2013Austrian DAL-HD studies. Pediatr Blood Cancer. 2010;55:1145\u201352. https:\/\/doi.org\/10.1002\/pbc.22664.","journal-title":"Pediatr Blood Cancer"},{"key":"2416_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijrobp.2014.09.010","volume":"91","author":"HJ van der Pal","year":"2015","unstructured":"van der Pal HJ, van Dijk IW, Geskus RB, Kok WE, Koolen M, Sieswerda E, et al. Valvular Abnormalities Detected by Echocardiography in 5-Year Survivors of Childhood Cancer: A Long-Term Follow-Up Study. Int J Radiat Oncol Biol Phys Elsevier. 2015;91:213\u201322. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.09.010.","journal-title":"Int J Radiat Oncol Biol Phys Elsevier"},{"key":"2416_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7326\/M15-0424","volume":"164","author":"DA Mulrooney","year":"2016","unstructured":"Mulrooney DA, Armstrong GT, Huang S, Ness KK, Ehrhardt MJ, Joshi VM, et al. Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-Sectional Study from the St. Jude Lifetime Cohort. Ann Intern Med. 2016;164:93\u2013101. https:\/\/doi.org\/10.7326\/M15-0424.","journal-title":"Ann Intern Med"},{"key":"2416_CR40","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","volume":"109","author":"BMP Aleman","year":"2006","unstructured":"Aleman BMP, van den Belt-Dusebout AW, De Bruin ML, van \u2019t Veer MB, Baaijens MHA, de Boer JP, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2006;109:1878\u201386. https:\/\/doi.org\/10.1182\/blood-2006-07-034405.","journal-title":"Blood"},{"key":"2416_CR41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2019.07.006","volume":"74","author":"MY Desai","year":"2019","unstructured":"Desai MY, Windecker S, Lancellotti P, Bax JJ, Griffin BP, Cahlon O, et al. Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease. JACC Am Coll Cardiol Foundation. 2019;74:905\u201327. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.006.","journal-title":"JACC Am Coll Cardiol Foundation"},{"key":"2416_CR42","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","volume":"290","author":"MC Hull","year":"2003","unstructured":"Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular Dysfunction and Carotid, Subclavian, and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated With Radiation Therapy. JAMA. 2003;290:2831\u20137. https:\/\/doi.org\/10.1001\/jama.290.21.2831.","journal-title":"JAMA"},{"key":"2416_CR43","doi-asserted-by":"publisher","first-page":"l6794","DOI":"10.1136\/bmj.l6794","volume":"368","author":"DA Mulrooney","year":"2020","unstructured":"Mulrooney DA, Hyun G, Ness KK, Ehrhardt MJ, Yasui Y, Duprez D, et al. Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort. BMJ. 2020;368:l6794. https:\/\/doi.org\/10.1136\/bmj.l6794.","journal-title":"BMJ"},{"key":"2416_CR44","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1200\/JCO.1993.11.7.1208","volume":"11","author":"SL Hancock","year":"1993","unstructured":"Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin\u2019s disease in children and adolescents. J Clin Oncol Wolters Kluwer. 1993;11:1208\u201315. https:\/\/doi.org\/10.1200\/JCO.1993.11.7.1208.","journal-title":"J Clin Oncol Wolters Kluwer"},{"key":"2416_CR45","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1200\/JCO.2010.33.4730","volume":"30","author":"HJ van der Pal","year":"2012","unstructured":"van der Pal HJ, van Dalen EC, van Delden E, van Dijk IW, Kok WE, Geskus RB, et al. High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors. J Clin Oncol Wolters Kluwer. 2012;30:1429\u201337. https:\/\/doi.org\/10.1200\/JCO.2010.33.4730.","journal-title":"J Clin Oncol Wolters Kluwer"},{"key":"2416_CR46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000495698","volume":"91","author":"DN Friedman","year":"2019","unstructured":"Friedman DN, Tonorezos ES, Cohen P. Diabetes and Metabolic Syndrome in Survivors of Childhood Cancer. Horm Res Paediatr. 2019;91:118\u201327. https:\/\/doi.org\/10.1159\/000495698.","journal-title":"Horm Res Paediatr"},{"key":"2416_CR47","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/bjh.12754","volume":"165","author":"KA Nottage","year":"2014","unstructured":"Nottage KA, Ness KK, Li C, Srivastava D, Robison LL, Hudson MM. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort. Br J Haematol. 2014;165:364\u201374. https:\/\/doi.org\/10.1111\/bjh.12754.","journal-title":"Br J Haematol"},{"key":"2416_CR48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1158\/1055-9965.EPI-09-0555","volume":"19","author":"LR Meacham","year":"2010","unstructured":"Meacham LR, Chow EJ, Ness KK, Kamdar KY, Chen Y, Yasui Y, et al. Cardiovascular Risk Factors in Adult Survivors of Pediatric Cancer\u2014A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2010;19:170\u201381. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-0555.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2416_CR49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaccao.2023.01.011","volume":"5","author":"DH Noyd","year":"2023","unstructured":"Noyd DH, Liu Q, Yasui Y, Chow EJ, Bhatia S, Nathan PC, et al. Cardiovascular Risk Factor Disparities in Adult Survivors of Childhood Cancer Compared With the General Population. JACC CardioOncology. 2023;5:489\u2013500. https:\/\/doi.org\/10.1016\/j.jaccao.2023.01.011.","journal-title":"JACC CardioOncology"},{"key":"2416_CR50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jpeds.2011.08.018","volume":"160","author":"J Steinberger","year":"2012","unstructured":"Steinberger J, Sinaiko AR, Kelly AS, Leisenring WM, Steffen LM, Goodman P, et al. Cardiovascular Risk and Insulin Resistance in Childhood Cancer Survivors. J Pediatr. 2012;160:494\u20139. https:\/\/doi.org\/10.1016\/j.jpeds.2011.08.018.","journal-title":"J Pediatr"},{"key":"2416_CR51","doi-asserted-by":"publisher","first-page":"1206071","DOI":"10.3389\/fmed.2023.1206071","volume":"10","author":"R Bhandari","year":"2023","unstructured":"Bhandari R, Armenian SH, McCormack S, Natarajan R, Mostoufi-Moab S. Diabetes in childhood cancer survivors: emerging concepts in pathophysiology and future directions. Front Med. 2023;10:1206071. https:\/\/doi.org\/10.3389\/fmed.2023.1206071.","journal-title":"Front Med"},{"key":"2416_CR52","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.3390\/biomedicines10123098","volume":"10","author":"F Mainieri","year":"2022","unstructured":"Mainieri F, Giannini C, Chiarelli F. Cardiovascular Risk in Childhood Cancer Survivors. Biomedicines. 2022;10:3098. https:\/\/doi.org\/10.3390\/biomedicines10123098.","journal-title":"Biomedicines"},{"key":"2416_CR53","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1158\/1055-9965.EPI-17-0510","volume":"26","author":"TM Gibson","year":"2017","unstructured":"Gibson TM, Li Z, Green DM, Armstrong GT, Mulrooney DA, Srivastava D, et al. Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study. Cancer Epidemiol Biomarkers Prev. 2017;26:1705\u201313. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-0510.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2416_CR54","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1200\/JCO.2003.06.131","volume":"21","author":"KC Oeffinger","year":"2003","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, et al. Obesity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor Study. J Clin Oncol. 2003;21:1359\u201365. https:\/\/doi.org\/10.1200\/JCO.2003.06.131.","journal-title":"J Clin Oncol"},{"key":"2416_CR55","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","volume":"39","author":"V Regitz-Zagrosek","year":"2018","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstr\u00f6m-Lundqvist C, C\u00edfkov\u00e1 R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165\u2013241. https:\/\/doi.org\/10.1093\/eurheartj\/ehy340.","journal-title":"Eur Heart J"},{"key":"2416_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11764-015-0457-8","volume":"10","author":"MR Hines","year":"2016","unstructured":"Hines MR, Mulrooney DA, Hudson MM, Ness KK, Green DM, Howard SC, et al. Pregnancy-associated cardiomyopathy in survivors of childhood cancer. J Cancer Surviv Res Pract. 2016;10:113\u201321. https:\/\/doi.org\/10.1007\/s11764-015-0457-8.","journal-title":"J Cancer Surviv Res Pract"},{"key":"2416_CR57","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jama.283.9.1183","volume":"283","author":"GD Pearson","year":"2000","unstructured":"Pearson GD, Veille J-C, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum Cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop Recommendations and Review. JAMA. 2000;283:1183. https:\/\/doi.org\/10.1001\/jama.283.9.1183.","journal-title":"JAMA"},{"key":"2416_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jaccao.2020.04.007","volume":"2","author":"M Nolan","year":"2020","unstructured":"Nolan M, Oikonomou EK, Silversides CK, Hines MR, Thompson KA, Campbell BA, et al. Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy. JACC CardioOncology. 2020;2:153\u201362. https:\/\/doi.org\/10.1016\/j.jaccao.2020.04.007.","journal-title":"JACC CardioOncology"},{"key":"2416_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijcard.2006.08.005","volume":"118","author":"J Abboud","year":"2007","unstructured":"Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: A comprehensive review. Int J Cardiol. 2007;118:295\u2013303. https:\/\/doi.org\/10.1016\/j.ijcard.2006.08.005.","journal-title":"Int J Cardiol"},{"key":"2416_CR60","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/cncr.31121","volume":"124","author":"JM Levine","year":"2018","unstructured":"Levine JM, Whitton JA, Ginsberg JP, Green DM, Leisenring WM, Stovall M, et al. Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer. 2018;124:1044\u201352. https:\/\/doi.org\/10.1002\/cncr.31121.","journal-title":"Cancer"},{"key":"2416_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1182\/blood-2007-05-090225","volume":"111","author":"ML De Bruin","year":"2008","unstructured":"De Bruin ML, Huisbrink J, Hauptmann M, Kuenen MA, Ouwens GM, van\u2019t Veer MB, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood. 2008;111:101\u20138. https:\/\/doi.org\/10.1182\/blood-2007-05-090225.","journal-title":"Blood"},{"key":"2416_CR62","doi-asserted-by":"publisher","first-page":"dju207","DOI":"10.1093\/jnci\/dju207","volume":"106","author":"AJ Swerdlow","year":"2014","unstructured":"Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, et al. Risk of Premature Menopause After Treatment for Hodgkin\u2019s Lymphoma. JNCI J Natl Cancer Inst. 2014;106:dju207. https:\/\/doi.org\/10.1093\/jnci\/dju207.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"2416_CR63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7827-8-20","volume":"8","author":"I Ben-Aharon","year":"2010","unstructured":"Ben-Aharon I, Bar-Joseph H, Tzarfaty G, Kuchinsky L, Rizel S, Stemmer SM, et al. Doxorubicin-induced ovarian toxicity. Reprod Biol Endocrinol RBE. 2010;8:20. https:\/\/doi.org\/10.1186\/1477-7827-8-20.","journal-title":"Reprod Biol Endocrinol RBE"},{"key":"2416_CR64","doi-asserted-by":"publisher","unstructured":"Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, Bittner VA, ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA et al. \/ASPC\/NLA\/PCNA Guideline on the Manage Dyslipidemia JACC. 2026;S0735109725102544. https:\/\/doi.org\/10.1016\/j.jacc.2025.11.016.","DOI":"10.1016\/j.jacc.2025.11.016"},{"key":"2416_CR65","doi-asserted-by":"publisher","unstructured":"Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency. Obstet Gynecol. 2017;129:e134. https:\/\/doi.org\/10.1097\/AOG.0000000000002044","DOI":"10.1097\/AOG.0000000000002044"},{"key":"2416_CR66","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/PPO.0000000000000591","volume":"28","author":"HN Hodis","year":"2022","unstructured":"Hodis HN, Mack WJ. Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease: It\u2019s About Time and Timing. Cancer J Sudbury Mass. 2022;28:208\u201323. https:\/\/doi.org\/10.1097\/PPO.0000000000000591.","journal-title":"Cancer J Sudbury Mass"},{"key":"2416_CR67","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.fertnstert.2016.09.046","volume":"106","author":"SD Sullivan","year":"2016","unstructured":"Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril Elsevier. 2016;106:1588\u201399. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.09.046.","journal-title":"Fertil Steril Elsevier"},{"key":"2416_CR68","unstructured":"Survivorship [Internet]. Child. Oncol. Group. [cited 2026 June 16]. https:\/\/childrensoncologygroup.org\/survivorship\/. Accessed 16 June 2026."},{"key":"2416_CR69","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1200\/JCO.2008.16.9607","volume":"26","author":"PC Nathan","year":"2008","unstructured":"Nathan PC, Greenberg ML, Ness KK, Hudson MM, Mertens AC, Mahoney MC, et al. Medical Care in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26:4401\u20139. https:\/\/doi.org\/10.1200\/JCO.2008.16.9607.","journal-title":"J Clin Oncol"},{"key":"2416_CR70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7326\/M13-1941","volume":"160","author":"E Suh","year":"2014","unstructured":"Suh E, Daugherty CK, Wroblewski K, Lee H, Kigin ML, Rasinski KA, et al. General Internists\u2019 Preferences and Knowledge About the Care of Adult Survivors of Childhood Cancer. Ann Intern Med. 2014;160:11\u20137. https:\/\/doi.org\/10.7326\/M13-1941.","journal-title":"Ann Intern Med"},{"key":"2416_CR71","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejca.2021.06.021","volume":"156","author":"EC van Dalen","year":"2021","unstructured":"van Dalen EC, Mulder RL, Suh E, Ehrhardt MJ, Aune GJ, Bardi E, et al. Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Eur J Cancer Elsevier. 2021;156:127\u201337. https:\/\/doi.org\/10.1016\/j.ejca.2021.06.021.","journal-title":"Eur J Cancer Elsevier"},{"key":"2416_CR72","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","volume":"16","author":"SH Armenian","year":"2015","unstructured":"Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, et al. Recommendations for Cardiomyopathy Surveillance for Survivors of Childhood Cancer: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16:e123\u201336. https:\/\/doi.org\/10.1016\/S1470-2045(14)70409-7.","journal-title":"Lancet Oncol"},{"key":"2416_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/JCO.2017.74.8673","volume":"36","author":"EJ Chow","year":"2018","unstructured":"Chow EJ, Chen Y, Hudson MM, Feijen EAM, Kremer LC, Border WL, et al. Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer. J Clin Oncol. 2018;36:44\u201352. https:\/\/doi.org\/10.1200\/JCO.2017.74.8673.","journal-title":"J Clin Oncol"},{"key":"2416_CR74","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41416-023-02410-y","volume":"129","author":"CS Rueegg","year":"2023","unstructured":"Rueegg CS, Z\u00fcrcher SJ, Schindera C, Jung R, Deng WH, B\u00e4nteli I, et al. Effect of a 1-year physical activity intervention on cardiovascular health in long-term childhood cancer survivors\u2014a randomised controlled trial (SURfit). Br J Cancer. 2023;129:1284\u201397. https:\/\/doi.org\/10.1038\/s41416-023-02410-y.","journal-title":"Br J Cancer"},{"key":"2416_CR75","doi-asserted-by":"publisher","first-page":"208","DOI":"10.6004\/jnccn.2025.0028","volume":"23","author":"T Sanft","year":"2025","unstructured":"Sanft T, Day AT, Ansbaugh SM, Ariza-Heredia EJ, Armenian S, Baker KS, et al. NCCN Guidelines\u00ae Insights: Survivorship, Version 2.2025: Featured Updates to the NCCN Guidelines\u00ae. J Natl Compr Canc Netw Natl Compr Cancer Netw. 2025;23:208\u201317. https:\/\/doi.org\/10.6004\/jnccn.2025.0028.","journal-title":"J Natl Compr Canc Netw Natl Compr Cancer Netw"},{"key":"2416_CR76","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1161\/CIR.0000000000001174","volume":"148","author":"D Addison","year":"2023","unstructured":"Addison D, Neilan TG, Barac A, Scherrer-Crosbie M, Okwuosa TM, Plana JC, et al. Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart Association. Circulation Am Heart Association. 2023;148:1271\u201386. https:\/\/doi.org\/10.1161\/CIR.0000000000001174.","journal-title":"Circulation Am Heart Association"},{"key":"2416_CR77","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.echo.2023.09.009","volume":"36","author":"L Mertens","year":"2023","unstructured":"Mertens L, Singh G, Armenian S, Chen M-H, Dorfman AL, Garg R, et al. Multimodality Imaging for Cardiac Surveillance of Cancer Treatment in Children: Recommendations From the American Society of Echocardiography. J Am Soc Echocardiogr. 2023;36:1227\u201353. https:\/\/doi.org\/10.1016\/j.echo.2023.09.009.","journal-title":"J Am Soc Echocardiogr"},{"key":"2416_CR78","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jaccao.2022.05.010","volume":"4","author":"R Aziz-Bose","year":"2022","unstructured":"Aziz-Bose R, Margossian R, Ames BL, Moss K, Ehrhardt MJ, Armenian SH, et al. Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy. JACC CardioOncology. 2022;4:354\u201367. https:\/\/doi.org\/10.1016\/j.jaccao.2022.05.010.","journal-title":"JACC CardioOncology"},{"key":"2416_CR79","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jchf.2023.07.009","volume":"11","author":"EM DeFilippis","year":"2023","unstructured":"DeFilippis EM, Bhagra C, Casale J, Ging P, Macera F, Punnoose L, et al. Cardio-Obstetrics and Heart Failure. JACC Heart Fail. 2023;11:1165\u201380. https:\/\/doi.org\/10.1016\/j.jchf.2023.07.009.","journal-title":"JACC Heart Fail"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02416-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02416-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02416-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:30:52Z","timestamp":1789716652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-026-02416-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02416-x","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"22 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No human or animal subjects were used by the authors in writing this review.","order":2,"name":"Ethics","label":"Human and animal rights and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"96"}}